 | ANI Pharmaceuticals, Inc. | |||
| NGM : ANIP || Location: United States | ||||
$65.48+0.9 (+1.39%) |
0.21 M | 64.2 - 65.78 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.197 M |
| March 15, 2024 | 0.262 M |
| Feb. 29, 2024 | 0.249 M |
| Feb. 15, 2024 | 0.213 M |
| Jan. 31, 2024 | 0.242 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 09/30/2023 | 0.86 | 1.27 | 47.64% |
| 06/30/2023 | 0.69 | 1.28 | 85.21% |
| 03/31/2023 | 0.36 | 1.17 | 225.36% |
| 12/31/2022 | 0.69 | 0.76 | 10.88% |
| 09/30/2022 | 0.55 | 0.64 | 16.40% |
ANIP Basic Data
| Sector | Healthcare | Industry | Drug Manufacturers - Specialty & Generic |
| Shares Outstanding | 20.980M | Shares Float | 15.035M |
| Short Float | 0.197M | Market Cap | 1373.77M |
| Institution ownership | 75.45% | Insider ownership | 11.201% |
| Earnings Date | 05/09/2024 BMO | Cash Per Share | ? |
| Trailing EPS | 0.85 | Forward EPS | 5.04 |